Literature DB >> 3145855

Value of surveillance cultures in the management of neutropenic patients.

M A Daw1, P Munnelly, S R McCann, P A Daly, F R Falkiner, C T Keane.   

Abstract

To assess whether bacteriological surveillance cultures can be used to predict infection in neutropenic patients, cultures were performed during the period of neutropenia of nose, throat and urine specimens collected once weekly and faeces specimens collected twice weekly. Seventy-six consecutively observed patients undergoing chemotherapy for haematological or non-haematological diseases were investigated. Severe infection including septicaemia, lower respiratory tract infection, anorectal lesion and urinary tract infection occurred in 32 patients. Enterobacter cloacae, Escherichia coli and Pseudomonas aeruginosa were the organisms most commonly involved. In the majority of cases of septicaemia the organisms were isolated from the faeces, often in pure culture, prior to the onset of septicaemia. Most of the isolates of Enterobacter cloacae were resistant to the empiric antibiotic therapy used in the unit and were able to colonise multiple sites, presumably increasing the risk of subsequent infection. Faecal culture is the most useful approach in bacteriological surveillance in neutropenic patients.

Entities:  

Mesh:

Year:  1988        PMID: 3145855     DOI: 10.1007/bf01975040

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  20 in total

1.  Management of infection in the neutropenic patient.

Authors:  R E Marcus; J M Goldman
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-16

2.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

Authors:  G P Bodey; M Buckley; Y S Sathe; E J Freireich
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

3.  Lessons learned from surveillance cultures in patients with acute nonlymphocytic leukemia. Usefulness for epidemiologic, preventive and therapeutic research.

Authors:  K A Newman; S C Schimpff; V M Young; P H Wiernik
Journal:  Am J Med       Date:  1981-02       Impact factor: 4.965

4.  Role of serial microbiologic surveillance and clinical evaluation in the management of cancer patients with fever and granulocytopenia.

Authors:  B S Kramer; P A Pizzo; K J Robichaud; F Witesbsky; R Wesley
Journal:  Am J Med       Date:  1982-04       Impact factor: 4.965

5.  Molecular analysis of multiple-resistance plasmids transferred from gram-negative bacteria isolated in a urological unit.

Authors:  H G Griffin; T J Foster; F R Falkiner; M E Carr; D C Coleman
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

6.  Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

Authors:  S C Schimpff; V M Young; W H Greene; G D Vermeulen; M R Moody; P H Wiernik
Journal:  Ann Intern Med       Date:  1972-11       Impact factor: 25.391

7.  Protective environment for marrow transplant recipients: a prospective study.

Authors:  C D Buckner; R A Clift; J E Sanders; J D Meyers; G W Counts; V T Farewell; E D Thomas
Journal:  Ann Intern Med       Date:  1978-12       Impact factor: 25.391

8.  Granulocytopenia in hospitalized patients: I. Prognostic factors and etiology of fever.

Authors:  M J Gurwith; J L Brunton; B A Lank; A R Ronald; G K Harding
Journal:  Am J Med       Date:  1978-01       Impact factor: 4.965

9.  Prediction by surveillance cultures of bacteremia among neutropenic patients treated in a protective environment.

Authors:  M L Cohen; M T Murphy; G W Counts; C D Buckner; R A Clift; J D Meyers
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

10.  Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients.

Authors:  H G de Vries-Hospers; D T Sleijfer; N H Mulder; D van der Waaij; H O Neiweg; H K van Saene
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

View more
  6 in total

1.  Molecular epidemiological study of Pseudomonas aeruginosa isolates from patients with acute leukemia.

Authors:  W Kern; C Wolz; G Döring
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

2.  Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia.

Authors:  Ryoko Yamasaki; Junya Kanda; Yu Akahoshi; Hirofumi Nakano; Tomotaka Ugai; Hidenori Wada; Koji Kawamura; Yuko Ishihara; Kana Sakamoto; Miki Sato; Masahiro Ashizawa; Tomohito Machishima; Kiriko Terasako-Saito; Shun-Ichi Kimura; Misato Kikuchi; Hideki Nakasone; Rie Yamazaki; Shinichi Kako; Junji Nishida; Yoshinobu Kanda
Journal:  Int J Hematol       Date:  2017-02-06       Impact factor: 2.490

3.  Characterization of a New Transposon, Tn6696, on a bla NDM- 1-Carrying Plasmid From Multidrug-Resistant Enterobacter cloacae ssp. dissolvens in China.

Authors:  Qichao Chen; Yanfeng Lin; Zhonghong Li; Lanfen Lu; Peihan Li; Kaiying Wang; Lang Yang; Hui Ma; Peng Li; Hongbin Song
Journal:  Front Microbiol       Date:  2020-09-15       Impact factor: 5.640

4.  Infection prevention requirements for the medical care of immunosuppressed patients: recommendations of the Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute.

Authors: 
Journal:  GMS Hyg Infect Control       Date:  2022-04-13

5.  [Requirements for hygiene in the medical care of immunocompromised patients. Recommendations from the Committee for Hospital Hygiene and Infection Prevention at the Robert Koch Institute (RKI)].

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2010-04       Impact factor: 1.513

6. 

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-02       Impact factor: 1.513

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.